UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 28, 2022
Accession Number:
Submission Type:
CIK:
0001818844
Company Name:
Virios Therapeutics, Inc.
File Number:
333-263700